I

MiNK Therapeutics
D

INKT

10.670
USD
-0.24
(-2.20%)
مغلق
حجم التداول
135
الربح لكل سهم
-4
العائد الربحي
-
P/E
-4
حجم السوق
50,086,634
المقالات

العنوان: MiNK Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.